Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are pregnant, have been diagnosed with migraine, and have taken at least one dose of rimegepant either during pregnancy or up to 3 days before becoming pregnant
- People who are pregnant, have been diagnosed with migraine, and have never taken rimegepant before or during pregnancy
Who may not be able to join:
- People who have taken certain other migraine medications — specifically a group of drugs called CGRP antagonists (such as ubrogepant), CGRP monoclonal antibodies, or a type of drug called ditans (such as lasmiditan) — at any point during pregnancy or in the days just before becoming pregnant (confirm with trial site if unsure which medications this includes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major congenital malformation (birth defect)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.